Alan Main
Keine laufenden Positionen mehr
Vermögen: 613 738 $ am 31.03.2024
Profil
Alan J.
Main served as the President & Chief Executive Officer at Coelacanth Corp.
from 2000 to 2001.
He then worked as the Senior Vice President-US Research at Novartis Pharmaceuticals Corp.
Following that, he held the position of Executive Vice President-Pharmaceutical Research at Lexicon Pharmaceuticals, Inc. from 2007 to 2015.
Dr. Main completed his undergraduate degree at the University of Aberdeen and obtained a doctorate from The University of Liverpool.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
18.03.2024 | 255 724 ( 0,10% ) | 613 738 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Alan Main
Unternehmen | Position | Ende |
---|---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Chief Executive Officer | 01.07.2001 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 11.03.2015 |
Ausbildung von Alan Main
University of Aberdeen | Undergraduate Degree |
The University of Liverpool | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |